| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Operating Officer
1 company
Veronique Lecault is Chief Operating Officer at ABCL. Veronique Lecault's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $25.9M at current prices.
Historically, Veronique Lecault's trades have earned a below-average insider score of 48/100 across 4 rated trades. Over a 12-month horizon, 25.0% of those trades were profitable, with an average 12-month return of -3.4%.
The ABCL filings lean toward selling, a net 526,211 shares.
Veronique Lecault has 15 Form 4 filings on record from December 2020 to January 2026, all as Chief Technology Officer at AbCellera Biologics (ABCL), 2020–2026.
The 18 reported transactions were 7 option or other derivative awards, 5 option exercises, 5 open-market purchases and 1 open-market sale.
Counted by filing, the open-market trades come to 4 purchases worth about $3.8M and 1 sale worth about $25.5M.
The largest open-market purchase was 230,789 shares of ABCL at an average $8.66 on February 28, 2022, about $2.0M. Twelve months later ABCL was down 4%.
The only open-market sale was 1,000,000 shares of ABCL at an average $25.50 on June 9, 2021, about $25.5M. Twelve months later ABCL was down 65%.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Sep 12, 2023 | ABCL Abcellera Biologics Inc. | Chief Operating Officer | Buy | 20,000 | $5.19 | $103,800.00 | +1.0% | -6.8% | -47.7% | |
| May 16, 2022 | ABCL Abcellera Biologics Inc. | Chief Operating Officer | Buy | 200,000 | $6.34 | $1,267,780.00 | +12.7% | +73.4% | -27.0% | |
| Feb 28, 2022 | ABCL Abcellera Biologics Inc. | Chief Operating Officer | Buy | 230,789 | $8.66 | $1,998,632.74 | +17.2% | -12.5% | -3.6% | |
| Jun 9, 2021 | ABCL Abcellera Biologics Inc. | Chief Operating Officer | Sell | 1,000,000 | $25.50 | $25,500,000.00 | -78.5% | -20.5% | -64.8% | |
| Dec 15, 2020 | ABCL Abcellera Biologics Inc. | Chief Operating Officer | Buy | 23,000 | $20.00 | $460,000.00 | +59.6% | - | - |